Aelin Therapeutics
0685.688.842 · rovalta.com · 26/09/2026
Aelin Therapeutics
Company — Voluntary dissolution - liquidation.
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAelin Therapeutics is a Public limited company incorporated in 2017. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Brugge.
- Legal situation
- Voluntary dissolution - liquidation
- BCE/KBO no. / VAT
- BE 0685.688.842
- Incorporation
- 06/12/2017
- Legal form
- Public limited company
- Registered office
- Lieven Bauwensstraat 20
8200 Brugge · FlandreSee on map - Contributed capital
- 25 833 330,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 30 k € | – | 234,3 € | -93.6% | 3,7 k € | -73.5% | 13,9 k € | ||
| EBITDA | -14,2 € | +100.0% | -245,2 k € | +71.7% | -866,8 k € | +78.8% | -4,1 M € | -280% | -1,1 M € |
| Operating result | 12,5 k € | +107% | -177,3 k € | -142% | 423,5 k € | +108% | -5,6 M € | +25.3% | -7,6 M € |
| Net result | 313,3 k € | +662% | 41,1 k € | -90.0% | 411,6 k € | +106% | -6,7 M € | +7.8% | -7,3 M € |
| Balance sheet | |||||||||
| Equity | -3,2 M € | +8.9% | -3,5 M € | +1.1% | -3,6 M € | +10.3% | -4 M € | -247% | 2,7 M € |
| Total assets | 2,1 M € | +14.7% | 1,8 M € | -4.2% | 1,9 M € | -48.7% | 3,7 M € | -48.4% | 7,2 M € |
| Cash | 1,8 M € | +14.6% | 1,6 M € | +21.8% | 1,3 M € | -49.5% | 2,6 M € | -45.0% | 4,6 M € |
| Debts | 5,3 M € | -0.6% | 5,3 M € | +1.1% | 5,3 M € | -14.3% | 6,2 M € | +39.1% | 4,4 M € |
| Other | |||||||||
| Workforce | – | – | 1,0 ETP | -96.5% | 28,3 ETP | -18.7% | 34,8 ETP | ||
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Lieven Bauwensstraat 20 8200 Brugge| Company | CBE no. |
|---|---|
BEDRIJVENCENTRUM REGIO BRUGGE● Active | 0426.225.225 |
Belgische Arbitrage Instelling● Active | 0468.089.831 |
BOUWONDERNEMING SANDERS● Liquidation | 0436.683.805 |
DANSPLATOO● Active | 0456.197.235 |
De Brugse Mosselcentrale● Active | 0466.133.005 |
Ecork Benelux● Bankrupt | 0692.951.172 |
FE GO24● Bankrupt | 0845.617.789 |
FLIN● Liquidation | 0436.263.735 |
GEUZEN● Bankrupt | 0897.497.646 |
INDECON● Active | 0847.300.542 |
INITIUM● Bankrupt | 0690.733.040 |
| 0410.022.859 | |
Mobility & Energy Company● Bankrupt | 0803.416.851 |
Mr. Franklin● Active | 0702.924.851 |
Pravida● Active | 1026.839.624 |
QWERIU● Active | 0673.809.708 |
RIDGETOP EUROPE● Active | 0468.231.074 |
SENIOR CONSULTANTS VLAANDEREN● Active | 0473.791.946 |
SHAPPIRO● Bankrupt | 0463.601.996 |
UILENSPIEGEL-BRUGGE● Bankrupt | 0515.943.493 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 23/06/2023 | 01/01/2023 | 01/01/2022 | 01/01/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 22/06/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 7 months | 6 months | 12 months | 12 months |
| Filing date | 10/08/2026 | 31/10/2025 | 19/08/2024 | 22/12/2023 | 06/07/2023 | 13/05/2022 |
| General meeting | 29/07/2026 | 27/10/2025 | 31/07/2024 | – | 22/06/2023 | 14/04/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/07/2026 | 10/08/2026 | Dutch | |
| Full model | 31/12/2024 | 27/10/2025 | 31/10/2025 | Dutch | |
| Full model | 31/12/2023 | 31/07/2024 | 19/08/2024 | Dutch | |
| Full model | 22/06/2023 | — | 22/12/2023 | Dutch | |
| Full model | 31/12/2022 | 22/06/2023 | 06/07/2023 | Dutch | |
| Full model | 31/12/2021 | 14/04/2022 | 13/05/2022 | Dutch | |
| Full model | 31/12/2020 | 30/04/2021 | 11/05/2021 | Dutch | |
| Full model | 31/12/2019 | 26/05/2020 | 29/06/2020 | Dutch | |
| Full model | 31/12/2018 | 28/05/2019 | 03/06/2019 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office31/10/2025MAATSCHAPPELIJKE ZETEL
- Registered office11/09/2023MAATSCHAPPELIJKE ZETEL
- Court decision03/08/2023RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Mandates08/11/2022ONTSLAGEN - BENOEMINGEN
- Mandates10/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates02/06/2022ONTSLAGEN - BENOEMINGEN
- Mandates17/02/2022ONTSLAGEN - BENOEMINGEN
- Mandates10/11/2021ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025313,3 k €↑
- 2024Annual accounts 202441,1 k €↓
- 2023Annual accounts 2023411,6 k €↑
- 2023Annual accounts 2023-6,7 M €↑
- 2022Annual accounts 2022-7,3 M €↓
- 2021Annual accounts 2021-5,6 M €↓
- 2020Annual accounts 2020-4,8 M €↓
- 2019Annual accounts 2019-3,3 M €↓
- 2018Annual accounts 2018-2,2 M €
- 06/12/2017IncorporationPublic limited company